Daiichi Sankyo Co Ltd (DSNKY)
33.56
+0.20
(+0.58%)
USD |
OTCM |
May 01, 15:59
Daiichi Sankyo Price to Book Value: 5.770 for May 1, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 30, 2024 | 5.737 |
| April 29, 2024 | 5.622 |
| April 26, 2024 | 5.536 |
| April 25, 2024 | 5.305 |
| April 24, 2024 | 5.243 |
| April 23, 2024 | 5.207 |
| April 22, 2024 | 5.178 |
| April 19, 2024 | 5.188 |
| April 18, 2024 | 5.085 |
| April 17, 2024 | 5.011 |
| April 16, 2024 | 5.068 |
| April 15, 2024 | 5.042 |
| April 12, 2024 | 5.13 |
| April 11, 2024 | 5.118 |
| April 10, 2024 | 5.060 |
| April 09, 2024 | 5.244 |
| April 08, 2024 | 5.312 |
| April 05, 2024 | 5.355 |
| April 04, 2024 | 5.334 |
| April 03, 2024 | 5.366 |
| April 02, 2024 | 5.242 |
| April 01, 2024 | 5.298 |
| March 31, 2024 | |
| March 28, 2024 | 5.422 |
| March 27, 2024 | 5.582 |
| Date | Value |
|---|---|
| March 26, 2024 | 5.497 |
| March 25, 2024 | 5.451 |
| March 22, 2024 | 5.557 |
| March 21, 2024 | 5.577 |
| March 20, 2024 | 5.638 |
| March 19, 2024 | 5.584 |
| March 18, 2024 | 5.618 |
| March 15, 2024 | 5.507 |
| March 14, 2024 | 5.374 |
| March 13, 2024 | 5.323 |
| March 12, 2024 | 5.504 |
| March 11, 2024 | 5.552 |
| March 08, 2024 | 5.557 |
| March 07, 2024 | 5.603 |
| March 06, 2024 | 5.640 |
| March 05, 2024 | 5.567 |
| March 04, 2024 | 5.560 |
| March 01, 2024 | 5.693 |
| February 29, 2024 | 5.601 |
| February 28, 2024 | 5.715 |
| February 27, 2024 | 5.833 |
| February 26, 2024 | 5.814 |
| February 23, 2024 | 5.637 |
| February 22, 2024 | 5.618 |
| February 21, 2024 | 5.620 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
2.685
Minimum
Mar 16 2020
6.538
Maximum
Jun 13 2023
4.494
Average
4.532
Median
Price to Book Value Benchmarks
| AstraZeneca PLC | 6.327 |
| Eisai Co Ltd | -- |
| Takeda Pharmaceutical Co Ltd | 0.8657 |
| Nxera Pharma Co Ltd | 1.757 |
| PeptiDream Inc | 5.939 |
Price to Book Value Related Metrics
| PE Ratio | 46.21 |
| PS Ratio | 5.818 |
| PEG Ratio | 0.6282 |
| Price to Free Cash Flow | 19.50 |
| Price | 33.56 |
| Earnings Yield | 2.16% |
| Market Cap | 64.36B |
| PEGY Ratio | 0.6220 |
| Operating PE Ratio | 44.03 |
| Normalized PE Ratio | 46.21 |